Current Pharmaceutical Design
Title:Editorial (Thematic Issue: Cardiovascular Prevention: Can We Do Any Better?)
Volume: 22 Issue: 37
Author(s): Aldo Pende and Fabrizio Montecucco
Affiliation:
Export Options
About this article
Cite this article as:
Pende Aldo and Montecucco Fabrizio, Editorial (Thematic Issue: Cardiovascular Prevention: Can We Do Any Better?), Current Pharmaceutical Design 2016; 22 (37) . https://dx.doi.org/10.2174/1381612822666160915095808
DOI https://dx.doi.org/10.2174/1381612822666160915095808 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
41
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Editorial Statins: [Hot Topic: Statins: Effects Beyond Cholesterol Lowering (Guest Editor: Garry X. Shen)]
Current Drug Targets - Cardiovascular & Hematological Disorders Controversies in Glaucoma: Current Medical Treatment and Drug Development
Current Pharmaceutical Design <i>In Silico</i> Based Structural and Fingerprint Analysis of Structurally Diverse AT1 inhibitors
Letters in Drug Design & Discovery 3,4-Dihydroxyphenylacetaldehyde: A Potential Target for Neuroprotective Therapy in Parkinsons Disease
Current Drug Targets - CNS & Neurological Disorders Hydralazine-Induced ANCA Associated Vasculitis (AAV) Presenting with Pulmonary-Renal Syndrome (PRS): A Case Report with Literature Review
Current Cardiology Reviews Oxidative Brain Damage by Peroxynitrite in Bacterial Meningitis: A Target for Adjunctive Therapy?
Current Medicinal Chemistry - Central Nervous System Agents Remote Control of Pulmonary Blood Flow
Current Cardiology Reviews Isolated Systolic Hypertension: Epidemiology, Pathogenesis and Treatment
Current Hypertension Reviews Editorial (Thematic Issue: Mechanistic Biomarkers: The Field for the Development of Non-Pharmaceutical and Pharmaceutical Approaches to Diagnostics, Prevention and Treatment of Chronic Diseases)
Current Pharmaceutical Design Systemic Sclerosis Associated Interstitial Lung Disease
Current Respiratory Medicine Reviews Impact of GLP-1 and GLP-1 Receptor Agonists on Cardiovascular Risk Factors in Type 2 Diabetes
Current Diabetes Reviews Exercise and Cardiovascular Disease
Cardiovascular & Hematological Disorders-Drug Targets Is Mania the Hypertension of the Mood? Discussion of A Hypothesis
Current Neuropharmacology Antihypertensive Therapy: Role of Aldosterone Antagonists
Current Pharmaceutical Design Current Options for the Pharmacotherapy of Obesity
Current Pharmaceutical Design Optimizing the Management of Uncontrolled/Resistant Hypertension. The Importance of Sleep Apnoea Syndrome
Current Vascular Pharmacology A Viewpoint on Angiotensin-Converting Enzyme 2, Anti-Hypertensives and Coronavirus Disease 2019 (COVID-19)
Infectious Disorders - Drug Targets Self-Organizing Maps in Drug Discovery: Compound Library Design, Scaffold-Hopping, Repurposing
Current Medicinal Chemistry Neurological Disorders in Pregnancy
Current Women`s Health Reviews Perspectives on the Tertiary Prevention Strategy for Alzheimer’s Disease
Current Alzheimer Research